Lanean...
Small molecule inhibitors in the treatment of cerebral ischemia
INTRODUCTION: Stroke is the world’s second leading cause of death. Although recombinant tissue plasminogen activator is an effective treatment for cerebral ischemia, its limitations and ischemic stroke’s complex pathophysiology dictate an increased need for the development of new therapeutic interve...
Gorde:
| Argitaratua izan da: | Expert Opin Pharmacother |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6986358/ https://ncbi.nlm.nih.gov/pubmed/24491068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14656566.2014.884560 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|